Truqap can be a kinase inhibitor that works by blocking pathways that support the cancer cells survive and expand, so reduces most cancers advancement. Truqap is from a category of medicines termed an AKT inhibitor. Truqap gained FDA approval on November 17, 2023, right after positive outcomes in the CAPItello-291 https://abduly110kvg3.wikibyby.com/user